Possible Beneficial Effects of N-Acetylcysteine for Treatment of Triple-Negative Breast Cancer

Possible Beneficial Effects of N-Acetylcysteine for Treatment of Triple-Negative Breast Cancer

N-acetylcysteine (NAC) is a widely used antioxidant with therapeutic potential. However, the cancer-promoting effect of NAC observed in some preclinical studies has raised concerns regarding its clinical use. Reactive oxygen species (ROS) can mediate signaling that results in both cancer-promoting a...

Full description

Bibliographic Details
Main Author:	Youngjoo Kwon
Format:	Article
Language:	English
Published:	MDPI AG 2021-01-01
Series:	Antioxidants
Subjects:	N-acetylcysteine triple-negative breast cancer reactive oxygen species antioxidant tumor microenvironment
Online Access:	https://www.mdpi.com/2076-3921/10/2/169

Similar Items

Tumor Microenvironment: Key Players in Triple Negative Breast Cancer Immunomodulation
by: Hongmei Zheng, et al.
Published: (2021-07-01)

Tumor-infiltrating lymphocytes in triple negative breast cancer
by: L. M. Zakhartseva, et al.
Published: (2020-12-01)

Molecular Mechanisms and Emerging Therapeutic Targets of Triple-Negative Breast Cancer Metastasis
by: Christiana Neophytou, et al.
Published: (2018-02-01)

Metabolic Reprogramming in Triple-Negative Breast Cancer
by: Xiangyu Sun, et al.
Published: (2020-03-01)

Fe(II) and Tannic Acid-Cloaked MOF as Carrier of Artemisinin for Supply of Ferrous Ions to Enhance Treatment of Triple-Negative Breast Cancer
by: Zihaoran Li, et al.
Published: (2021-02-01)

Hindering triple negative breast cancer progression by targeting endogenous interleukin‐30 requires IFNγ signaling
by: Carlo Sorrentino, et al.
Published: (2021-02-01)

Enhanced Thermogenesis in Triple-Negative Breast Cancer Is Associated with Pro-Tumor Immune Microenvironment
by: Shipra Gandhi, et al.
Published: (2021-05-01)

Protective Effects of N-acetylcysteine Against the Statins Cytotoxicity in Freshly Isolated Rat Hepatocytes
by: Narges Abdoli, et al.
Published: (2014-05-01)

Mesenchymal Cells Support the Oncogenicity and Therapeutic Response of the Hedgehog Pathway in Triple-Negative Breast Cancer
by: Ana M. Reyes-Ramos, et al.
Published: (2019-10-01)

Immune Cell Infiltration-Based Characterization of Triple-Negative Breast Cancer Predicts Prognosis and Chemotherapy Response Markers
by: Yufei Lv, et al.
Published: (2021-03-01)

Simultaneous blockade of IL-6 and CCL5 signaling for synergistic inhibition of triple-negative breast cancer growth and metastasis
by: Kideok Jin, et al.
Published: (2018-06-01)

Current Progresses and Challenges of Immunotherapy in Triple-Negative Breast Cancer
by: Karan Mediratta, et al.
Published: (2020-11-01)

Pilose antler polypeptides promote chemosensitization and T-cell infiltration of triple-negative breast cancer
by: Mohan Li, et al.
Published: (2021-10-01)

THE ROLE OF TUMOR-INFILTRATING LYMPHOCYTES IN TRIPLE NEGATIVE BREAST CANCER
by: Anca Zgura, et al.
Published: (2018-09-01)

Active behavior of triple-negative breast cancer with adipose tissue invasion: a single center and retrospective review
by: Junzo Yamaguchi, et al.
Published: (2021-04-01)

Unraveling Heterogeneity of Tumor Cells and Microenvironment and Its Clinical Implications for Triple Negative Breast Cancer
by: Ke Jiang, et al.
Published: (2021-03-01)

Therapy With Carboplatin and Anti-PD-1 Antibodies Before Surgery Demonstrates Sustainable Anti-Tumor Effects for Secondary Cancers in Mice With Triple-Negative Breast Cancer
by: Meizhuo Gao, et al.
Published: (2020-03-01)

Prognostic Effect of Microenvironment Phenotype in Triple-Negative Breast Cancer: Biomarker Analysis of a Prospective Trial
by: Si-Yuan Zhu, et al.
Published: (2021-09-01)

Atractylenolide-I Sensitizes Triple-Negative Breast Cancer Cells to Paclitaxel by Blocking CTGF Expression and Fibroblast Activation
by: Meng Wang, et al.
Published: (2021-10-01)

A clinicopathologic study of triple negative breast cancer
by: Vandana L Gaopande, et al.
Published: (2015-01-01)

Dual-Specificity Phosphatase 1 (DUSP1) Has a Central Role in Redox Homeostasis and Inflammation in the Mouse Cochlea
by: Jose M. Bermúdez-Muñoz, et al.
Published: (2021-08-01)

Gene signature‐based prediction of triple‐negative breast cancer patient response to Neoadjuvant chemotherapy
by: Yanding Zhao, et al.
Published: (2020-09-01)

Influence of N-Acetylcysteine on Oxidative Stress in Slow-Twitch Soleus Muscle of Heart Failure Rats
by: Paula F. Martinez, et al.
Published: (2015-01-01)

Optimal Regimen of N-Acetylcysteine on Chromium-Induced Renal Cell Damage
by: I-Jeng Yeh, et al.
Published: (2019-08-01)

Prophylactic and Ameliorative Effect of N-Acetylcysteine on Doxorubicin-Induced Neurotoxicity in Wister Rats
by: Walaa I. Mohammed, et al.
Published: (2019-01-01)

High Throughput Transcriptome Data Analysis and Computational Verification Reveal Immunotherapy Biomarkers of Compound Kushen Injection for Treating Triple-Negative Breast Cancer
by: Xinkui Liu, et al.
Published: (2021-09-01)

Understanding Patterns of Brain Metastasis in Triple-Negative Breast Cancer and Exploring Potential Therapeutic Targets
by: Lv Y, et al.
Published: (2021-01-01)

VISTA Expression on Immune Cells Correlates With Favorable Prognosis in Patients With Triple-Negative Breast Cancer
by: Xi Cao, et al.
Published: (2021-01-01)

The opposing effects of interferon-beta and oncostatin-M as regulators of cancer stem cell plasticity in triple-negative breast cancer
by: Mary R. Doherty, et al.
Published: (2019-04-01)

Immunohistochemical Differentiation of Triple Negative Breast Cancer
by: Nikola Lesar, et al.
Published: (2016-01-01)

Immune microenvironment changes induced by neoadjuvant chemotherapy in triple-negative breast cancers: the MIMOSA-1 study
by: Victor Sarradin, et al.
Published: (2021-05-01)

Carnosol, a Natural Polyphenol, Inhibits Migration, Metastasis, and Tumor Growth of Breast Cancer via a ROS-Dependent Proteasome Degradation of STAT3
by: Halima Alsamri, et al.
Published: (2019-08-01)

HER3 Differentiates Basal From Claudin Type Triple Negative Breast Cancer and Contributes to Drug and Microenvironmental Induced Resistance
by: Nicoleta Sinevici, et al.
Published: (2020-11-01)

N-acetylcysteine: an old drug with variable Anti-influenza properties
by: Tomas Casanova, et al.
Published: (2016-03-01)

Identification of a Hypoxia-Related Molecular Classification and Hypoxic Tumor Microenvironment Signature for Predicting the Prognosis of Patients with Triple-Negative Breast Cancer
by: Xiaoli Sun, et al.
Published: (2021-08-01)

MicroRNAs and Triple Negative Breast Cancer
by: Marilena V. Iorio, et al.
Published: (2013-11-01)

A Novel Three-Gene Score as a Predictive Biomarker for Pathologically Complete Response after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
by: Masanori Oshi, et al.
Published: (2021-05-01)

New chemotherapy options for triple-negative breast cancer (review of literature)
by: M A Sekundova, et al.
Published: (2014-03-01)

Transcriptomic analyses identify key differentially expressed genes and clinical outcomes between triple-negative and non-triple-negative breast cancer
by: Chen B, et al.
Published: (2018-12-01)

Triple-Negative Breast Cancer Survival in Iranian Patients
by: Mahdi Aghili, et al.
Published: (2013-08-01)